Advances in Microbiology, 2013, 3, 1-13 http://dx.doi.org/10.4236/aim.2013.31001 Published Online March 2013 (http://www.scirp.org/journal/aim) Diversity and Bioactivity of Cultivable Animal Fecal Actinobacteria Yi Jiang1*, Li Han2, Xiu Chen1, Min Yin1, Dan Zheng2, Yong Wang3, Shumei Qiu4, Xueshi Huang2 1Yunnan Institute of Microbiology, Yunnan University, Kunming, China 2Lab of Metabolic Disease Research and Drug Development, China Medical University, Shenyang, China 3Sanqi Research Institute of Wenshan, Wenshan, China 4Yunnan Wild Animal Park, Kunming, China Email: *
[email protected],
[email protected],
[email protected],
[email protected],
[email protected],
[email protected],
[email protected],
[email protected] Received November 2, 2012; revised December 4, 2012; accepted January 5, 2013 ABSTRACT Microbial symbionts play important roles in food digestion and absorption, immunity, pathogens resistance, and health maintaining of their hosts by co-evolution. To provide new sources for discovering new leader compounds of drugs, the diversity and bioactivities of cultivable actinobacteria from animal feces have been studied. 31 species of animal fecal samples were collected from Yunnan Wild Animal Park. The purified cultures of actinobacteria were isolated from these samples by using 5 media. The 16S rRNA gene sequences of 528 selected strains were determined, the phyloge- netic analysis was carried out, and anti-microbial and anti-tumor activities were determined. 35 genera (including a new genus, Enteractinococcus) of actinobacteria from the 31 species of animal feces were identified. Some strains had high anti-tumor and antimicrobial activities. More than 50 secondary metabolites were isolated and identified, a novel bioactive macrolactam polyketide glycoside, Sannastatin, was found.